Abstract

BackgroundAlcadein proteins (Alcs; Alcα, Alcβand Alcγ) are predominantly expressed in neurons, as is Alzheimer's β-amyloid (Aβ) precursor protein (APP). Both Alcs and APP are cleaved by primary α- or β-secretase to generate membrane-associated C-terminal fragments (CTFs). Alc CTFs are further cleaved by γ-secretase to secrete p3-Alc peptide along with the release of intracellular domain fragment (Alc ICD) from the membrane. In the case of APP, APP CTFβ is initially cleaved at the ε-site to release the intracellular domain fragment (AICD) and consequently the γ-site is determined, by which Aβ generates. The initial ε-site is thought to define the final γ-site position, which determines whether Aβ40/43 or Aβ42 is generated. However, initial intracellular ε-cleavage sites of Alc CTF to generate Alc ICD and the molecular mechanism that final γ-site position is determined remains unclear in Alcs.MethodologyUsing HEK293 cells expressing Alcs plus presenilin 1 (PS1, a catalytic unit of γ-secretase) and the membrane fractions of these cells, the generation of p3-Alc possessing C-terminal γ-cleavage site and Alc ICD possessing N-terminal ε-cleavage site were analysed with MALDI-TOF/MS. We determined the initial ε-site position of all Alcα, Alcβ and Alcγ, and analyzed the relationship between the initially determined ε-site position and the final γ-cleavage position.ConclusionsThe initial ε-site position does not always determine the final γ-cleavage position in Alcs, which differed from APP. No additional γ-cleavage sites are generated from artificial/non-physiological positions of ε-cleavage for Alcs, while the artificial ε-cleavage positions can influence in selection of physiological γ-site positions. Because alteration of γ-secretase activity is thought to be a pathogenesis of sporadic Alzheimer's disease, Alcs are useful and sensitive substrate to detect the altered cleavage of substrates by γ-secretase, which may be induced by malfunction of γ-secretase itself or changes of membrane environment for enzymatic reaction.

Highlights

  • The c-secretase is comprised of four membrane proteins, presenilin 1 (PS1) or 2 (PS2), nicastrin (NCT), anterior pharynx defective 1 (APH-1), and presenilin enhancer 2 (PEN-2) [1]

  • No additional c-cleavage sites are generated from artificial/non-physiological positions of e-cleavage for Alcadein proteins (Alcs), while the artificial e-cleavage positions can influence in selection of physiological c-site positions

  • Because alteration of c-secretase activity is thought to be a pathogenesis of sporadic Alzheimer’s disease, Alcs are useful and sensitive substrate to detect the altered cleavage of substrates by c-secretase, which may be induced by malfunction of c-secretase itself or changes of membrane environment for enzymatic reaction

Read more

Summary

Introduction

The c-secretase is comprised of four membrane proteins, presenilin 1 (PS1) or 2 (PS2), nicastrin (NCT), anterior pharynx defective 1 (APH-1), and presenilin enhancer 2 (PEN-2) [1]. When CTFb is further cleaved by c-secretase, the AD-related amyloid b protein (Ab) is generated, while metabolically labile p3 peptide is generated from CTFa by c-cleavage This intramembrane c-cleavage of APP CTF occurs initially at ecleavage sites. When alternative e-cleavage occurs between Thr644 and Leu645, Ab48, Ab45, and Ab42 are sequentially generated, and cleavage at Gly634 generates Ab38 These Ab peptides are generated by processing of every three to four amino acids from the initial e-site by c-secretase [6,7,8,9,10].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call